Implementation of antibiotic management teams in Belgian hospitals

Acta Clinica Belgica

Volumn 61, Issue 2, 2006, Pages 58-63

  Sourdeau, L ^a   Struelens, M J ^b   Peetermans, W E ^c,e   Costers, M ^d   Suetens, C ^a,e   Byl, B ^e   De Jongh, M ^e   Delaere, B ^e   Ernes, Ch ^e   Gordts, B ^e   Govaerts, D ^e   Lacor, P ^e   Peleman, R ^e   Robays, H ^e   Van Laethem, Y ^e   Verhaegen, Y ^e  

^a Institut Scientifique de Sante Publique   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Belgian Antibiotic Policy Coordination Committee   (Belgium)

^e NONE

Author keywords

Antibiotic policy; Belgium; Hospital

Indexed keywords

ANTIBIOTIC AGENT;

BELGIUM; DRUG USE; HEALTH SERVICE; HOSPITAL; HOSPITAL MANAGEMENT; HOSPITAL PERSONNEL MANAGEMENT; REVIEW;

EID: 33646805794     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2006.011     Document Type: Review

References (50)

1. Ioanas M, Cavalcanti M, Ferrer M, Valencia M, Agusti C, Puig dlB et al. Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J 2003; 22(6):876-82.
2. Odeh R, Kelkar S, Hujer AM, Bonomo RA, Schreckenberger PC, Quinn JP. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clin Infect Dis 2002; 35(2): 140-5.
3. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Jr., Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42(6): 2398-402.
4. Su LH, Chiu CH, Chu C, Wang MH, Chia JH, Wu TL. In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum. Antimicrob Agents Chemother 2003; 47(2):563-7.
5. Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103(1):173-81.
6. Woods CW, Cheng AC, Fowler VG, Jr., Moorefield M, Frederick J, Sakoulas G et al. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis 2004; 38(8):1188-91.
7. Chenoweth C, Lynch JP, III. Antimicrobial resistance: implications for managing respiratory failure. Curr Opin Pulm Med 1997; 3(2): 159-69.
8. Du B, Long Y, Liu H, Chen D, Liu D, Xu Y et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002; 28(12):1718-23.
9. Fish DN, Piscitelli SC, Danziger LH. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 1995; 15(3):79-291.
10. Goossens H, Peetermans W, Sion JP, Bossens M. ['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system]. Ned Tijdschr Geneeskd 2001; 145(37):1773-7.
11. Gupta N, Yadav A, Choudhary U, Arora DR. Citrobacter bacteremia in a tertiary care hospital. Scand J Infect Dis 2003; 35(10):765-8.
12. Conclusions of the European Union Conference on 'The microbial threat', 9-10 September 1998. The Copenhagen Recommendation. Ministry of Health Ministry of Food, Agriculture and Fisheries. Vet Res 1999; 30(1):119-22.
13. Commision Recommandation on Prudent Use of Antimicrobial Agents in Human Medecin. Official Journal of the European Communities 5 2 2002 L 34/13 2001.
14. Bantar C, Sartori B, Vesco E, Heft C, Saul M, Salamone F et al. A hospital-wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37(2):180-6.
15. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisdplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24(9):699-706.
16. Gums JG, Yancey RW, Jr., Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999; 19(12):1369-77.
17. Legrand JC, Struelens M. [For rational use of antibiotics in the hospital]. Rev Med Brux 2001; 22(1):15-25.
18. Pacey S, Warner J, Li Wan PA. A multidisciplinary approach to hospital-based drug cost containment. J Clin Pharm Ther 1998; 23(3):203-11.
19. Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A, Chouaid C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect 2003; 53(3):177-82.
20. Dickerson LM, Mainous AG, III, Carek PJ. The pharmacist's role in promoting optimal antimicrobial use. Pharmacotherapy 2000; 20(6):711-23.
21. Nathwani D, Gray K, Borland H. Quality indicators for antibiotic control programmes. J Hosp Infect 2002; 50(3):165-9.
22. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998; 19(2):114-24.
23. Struelens MJ. Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. Curr Opin Infect Dis 2003; 16(4):305-7.
24. van Kasteren ME, Gyssens IC, Kullberg BJ, Bruining HA, Stobberingh EE, Goris RJ. [Optimizing antibiotics policy in the Netherlands. V. SWAB guidelines for perioperative antibiotic prophylaxis. Foundation Antibiotics Policy Team]. Ned Tijdschr Geneeskd 2000; 144(43):2049-55.
25. Wolf S, Leitritz L, Rupp C, Schlondorff D, Bogner JR. Cost reduction after introduction of a multidisciplinary infectious disease service at a German university hospital. Infection 2000; 28(6):379-83.
26. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29(1):60-6.
27. John JF, Jr., Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24(3):471-85.
28. Sintchenko V, Iredell JR, Gilbert GL, Coiera E. What do physicians think about evidence-based antibiotic use in critical care? A survey of Australian intensivists and infectious disease practitioners. Intern Med J 2001; 31(8):462-9.
29. Stevenson RC, Blackman SC, Williams CL, Bartzokas CA. Measuring the saving attributable to an antibiotic prescribing policy. J Hosp Infect 1988; 11(1):16-25.
30. Brown EM. Guidelines for antibiotic usage in hospitals. J Antimicrob Chemother 2002; 49(4):587-92.
31. Gyssens IC, Geerligs IE, Dony JM, van der Vliet JA, van Kampen A, van den Broek PJ et al. Optimising antimicrobial drug use in surgery: an intervention study in a Dutch university hospital. J Antimicrob Chemother 1996; 38(6):1001-12.
32. Natsch S, van Kasteren ME, Kullberg BJ, van der Meer JW. Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1998; 26(6):1482-3.
33. Natsch S, Kullberg BJ, Meis JF, van der Meer JW. Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department. Arch Intern Med 2000; 160(9):1317-20.
34. Peetermans WE. Prophylactic, empiric and therapeutic use of antibiotics. Do we need a guide: a universal edition or a local one? Eur J Emerg Med 1997; 4(1):15-8.
35. Struelens MJ, Peetermans WE. The antimicrobial resistance crisis in hospitals calls for multidisciplinary mobilization. Acta Clin Belg 1999; 54(1):2-6.
36. Widdison AL, Pope NR, Brown EM. Survey of guidelines for antimicrobial prophylaxis in surgery. J Hosp Infect 1993; 25(3):199-205.
37. Bassetti M, Di Biagio A, Rebesco B, Cenderello G, Amalfitano ME, Bassetti D. Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int J Antimicrob Agents 2000; 16(3):295-9.
38. Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 2001; 57(6-7):529-34.
39. Gould IM, Jappy B. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. J Antimicrob Chemother 1996; 38(5):895-904.
40. Lawton RM, Fridkin SK, Gaynes RP, McGowan JE, Jr. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000; 21(4):256-9.
41. Snyder LL, Clyne KE, Wagner JC. Antibiotic sensitivity and the prescribing information sheet: assisting the prescribing physician. Am J Infect Control 1990; 18(6):399-404.
42. Vlahovic-Palcevski V, Morovic M, Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 2000; 56(1):97-101.
43. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP et al. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA 1996; 275(3):234-40.
44. Kolmos HJ. Interaction between the microbiology laboratory and clinician: what the microbiologist can provide. J Hosp Infect 1999; 43 Suppl:S285-91.
45. Steward CD, Wallace D, Hubert SK, Lawton R, Fridkin SK, Gaynes RP et al. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. Diagn Microbiol Infect Dis 2000; 38(1):59-67.
46. Struelens M, Delforge ML, Denis O, Liesnard C, Rodriguez-Villalobos H. [The microbiology department]. Rev Med Brux 2002; 23 Suppl 2: 107-10.
47. Gyssens IC, Geerligs IE, Nannini-Bergman MG, Knape JT, Hekster YA, van der Meer JW. Optimizing the timing of antimicrobial prophylaxis in surgery: an intervention study. J Antimicrob Chemother 1996; 38(2):301-8.
48. Gyssens IC, Blok WL, van den Broek PJ, Hekster YA, van der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997; 16(12): 904-12.
49. Richardson LP, Wiseman SW, Malani PN, Lyons MJ, Kauffman CA. Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff. Microb Drug Resist 2000; 6(4): 327-30.
50. van der Meer JW, Gyssens IC. Quality of antimicrobial drug prescription in hospital. Clin Microbiol Infect 2001; 7 Suppl 6:12-5.